Serum vitamin D3 does not correlate with liver fibrosis in chronic hepatitis C

Table 1 Characteristics of patients and controls

Features	Patients (n = 120)	Controls (n = 11)
Male/female	57/63	4/7
Age (yr)	51.33 ± 7.33	38.45 ± 6.95
BMI (kg/m2)	22.34 ± 2.73	24.00 ± 2.53
ALT (U/L)	60.42 ± 70.88	16.71 ± 5.14
AST (U/L)	47.94 ± 44.30	19.87 ± 3.49
TBIL (µmol/L)	16.51 ± 7.25	16.30 ± 5.64
DBIL (µmol/L)	3.26 ± 1.36	2.82 ± 0.75
TP (g/L)	70.93 ± 4.95	69.05 ± 3.15
ALB (g/L)	43.24 ± 2.36	43.86 ± 2.18
GGT (U/L)	22.04 ± 16.50	15.90 ± 10.82
CHE (U/L)	6657.09 ± 1442.44	7703.45 ± 945.75
Ca (mmol/L)	2.26 ± 0.08	2.21 ± 0.05
P (mmol/L)	0.92 ± 0.19	1.02 ± 0.14
HB (g/L)	151.09 ± 16.56	144.45 ± 11.43
PLT (× 109/L)	171.36 ± 53.20	242.18 ± 48.36
PTA (%)	92.41 ± 9.11	93.78 ± 4.69
Virus load, n (%)
< 4 log10	20 (16.7)
4-5 log10	52 (43.3)
6-7 log10	48 (40.0)
Stage of fibrosis, n (%)
0	1 (0.8)
1	55 (45.8)
2	50 (47.1)
3	12 (10)
4	2 (1.7)
Grade of inflammation, n (%)
0	1 (0.8)
1	16 (13.3)
2	67 (55.8)
3	34 (28.3)
4	2 (1.7)

BMI: Body Mass Index; ALT: Alanine Aminotransferase; AST: Aspartate Aminotransferase; TBIL: Total Bilirubin; DBIL: Direct Bilirubin; TP: Total Protein; ALB: Albumin; GGT: Gamma-glutamyl Transpeptidase; CHE: Cholinesterase; HB: Hemoglobin; PLT: Platelets; PTA: Prothrombin Time Activity.